Intensive diabetes management for high-risk patients: how best to deliver?
Marshall
Sally M
SM
D000419:Albuminuria / Q000517:prevention & control; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000401:mortality / Q000517:prevention & control; D003695:Delivery of Health Care / Q000592:standards*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control; D003928:Diabetic Nephropathies / Q000517:prevention & control / Q000628:therapy*; D003930:Diabetic Retinopathy / Q000517:prevention & control; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control; D019808:Losartan / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D019808:Losartan